Cost-effectiveness/utility of PCV13 versus no routine vaccination in moderate/high-risk Belgian adults aged 65–84 years.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
Cost-effectiveness/utility of PCV13 versus no routine vaccination in moderate/high-risk Belgian adults aged 65–84 years.
创建时间：
2018-07-06
